What Is Behind The Post-Recession Bend In The Health Care Cost Curve?

This all suggests that the vast majority of the post-recession slowdown is attributable to lower economy-wide price inflation along with some temporary noncyclical factors. Of the surprisingly small amount left to be explained by the recession and structural changes, I would attribute the greatest share to the recession.

Small Business Employers Beware: Check Your Options Before Using the State Health Exchange

As of October 17, 2014 small businesses (50 or fewer employees) now have a broader choice of small group insurance plans through the Washington State Health Benefit Exchange. Regrettably the HBE has chosen to push its plans even where those plans may not be the best solution for a small business or its workforce. The fact that they are using public funds to market this approach has raised additional concerns.

OP/ED-Biosimilar Drugs Require More Transparent Communication Between Patient and Pharmacist: SB 5935 Needs Work

Very recently during the 64th Legislature in the State of Washington, House Bill 1675 was introduced relating to the prescription of biological products and interchangeable biological products.   The bill addressed the process through which a biosimilar that has been given ‘interchangeable’ status by the FDA can be substituted for the innovator biologic it mimics.

Guest Op-Ed: Rectifying Surgical Patient Safety

You and your doctor decide you need surgery. As you are lying on the operating room (O.R.) table looking up at the ‘many faces behind the masks,’ do you ask yourself, “did everyone here graduate from an accredited program before being hired?” As a healthcare consumer, chances are that you expect all healthcare professionals, regardless

Using Drugs to Discriminate — Adverse Selection in the Insurance Marketplace

A formal complaint submitted to the Department of Health and Human Services in May 2014 contended that Florida insurers offering plans through the new federal marketplace (exchange) had structured their drug formularies to discourage people with human immunodeficiency virus infection from selecting their plans.